Abstract
L-Asparaginase was used to treat 40 patients with acute leukaemia or lymphosarcoma. Fifteen with acute lymphoblastic leukaemia either untreated or in relapse after previous therapy were given “Squibb,” “Bayer,” or “Porton” L-asparaginase. Five of these patients had complete remission of their disease, and four had good partial remission. Eleven patients with acute myeloid leukaemia were treated for a short period with L-asparaginase alone. None of them went into remission though a pronounced fall in the numbers of circulating white cells was seen. Six patients with lymphosarcoma received L-asparaginase, two of them having good partial remissions.
The toxic side-effects of the L-asparaginase from the three sources seemed to vary, and L-asparaginase from Erwinia carotovora appeared to be antigenically different from the enzyme produced by Escherichia coli.
The way in which leukaemic cells become resistant to the action of the enzyme requires further investigation. To overcome this resistance asparaginase should be used in combination with other drugs in the treatment of acute leukaemia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BROOME J. D. Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance. J Exp Med. 1963 Jul;118:99–120. doi: 10.1084/jem.118.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KIDD J. G. Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum. J Exp Med. 1953 Dec;98(6):565–582. doi: 10.1084/jem.98.6.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MASHBURN L. T., WRISTON J. C., Jr TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI. Arch Biochem Biophys. 1964 May;105:450–452. doi: 10.1016/0003-9861(64)90032-3. [DOI] [PubMed] [Google Scholar]
- McElwain T. J., Hardisty R. M. Remission induction with cytosine arabinoside and L-asparaginase in acute lymphoblastic leukaemia. Br Med J. 1969 Dec 6;4(5683):596–598. doi: 10.1136/bmj.4.5683.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- OLD L. J., BOYSE E. A., CAMPBELL H. A., DARIA G. M. Leukaemia-inhibiting properties and L-asparaginase activity of sera from certain South American rodents. Nature. 1963 May 25;198:801–801. doi: 10.1038/198801a0. [DOI] [PubMed] [Google Scholar]
- Oettgen H. F., Old L. J., Boyse E. A., Campbell H. A., Philips F. S., Clarkson B. D., Tallal L., Leeper R. D., Schwartz M. K., Kim J. H. Inhibition of leukemias in man by L-asparaginase. Cancer Res. 1967 Dec;27(12):2619–2631. [PubMed] [Google Scholar]
- Oettgen H. F., Schulten H. K. Hemmung maligner Neoplasien des Menschen durch L-Asparaginase. Klin Wochenschr. 1969 Jan 15;47(2):65–71. doi: 10.1007/BF01745767. [DOI] [PubMed] [Google Scholar]
- Schein P. S., Rakieten N., Gordon B. M., Davis R. D., Rall D. P. The toxicity of Escherichia coli L-asparaginase. Cancer Res. 1969 Feb;29(2):426–434. [PubMed] [Google Scholar]
- Schmidt C. G., Gallmeier W. M. Zur Enzymtherapie der Leukämien. Dtsch Med Wochenschr. 1968 Nov 29;93(48):2299–2309. doi: 10.1055/s-0028-1110930. [DOI] [PubMed] [Google Scholar]